170 related articles for article (PubMed ID: 3885674)
1. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
Conway SP; Miller MG; Ramsden C; Littlewood JM
Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
[TBL] [Abstract][Full Text] [Related]
2. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
Gold R; Overmeyer A; Knie B; Fleming PC; Levison H
Pediatr Infect Dis; 1985; 4(2):172-7. PubMed ID: 3885181
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
Schaad UB; Desgrandchamps D; Kraemer R
Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
[TBL] [Abstract][Full Text] [Related]
4. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
Parry MF; Neu HC
J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
Jansen W; Schwarz A
Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
[TBL] [Abstract][Full Text] [Related]
6. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis.
Penketh AR; Hodson ME; Batten JC
Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085
[TBL] [Abstract][Full Text] [Related]
7. Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis.
Jackson MA; Kusmiesz H; Shelton S; Prestidge C; Kramer RI; Nelson JD
Pediatr Infect Dis; 1986; 5(4):440-3. PubMed ID: 3725655
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis.
Jewett CV; Ledbetter J; Lyrene RK; Brasfield DM; Tiller RE
J Pediatr; 1985 Apr; 106(4):669-72. PubMed ID: 3845095
[No Abstract] [Full Text] [Related]
9. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin.
Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR
J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521
[TBL] [Abstract][Full Text] [Related]
10. Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
Caplan DB; Buchanan CN
Rev Infect Dis; 1984; 6 Suppl 3():S705-10. PubMed ID: 6443771
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
Parry MF; Neu HC
Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
[TBL] [Abstract][Full Text] [Related]
12. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA
J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.
Martin AJ; Smalley CA; George RH; Healing DE; Anderson CM
Arch Dis Child; 1980 Aug; 55(8):604-7. PubMed ID: 7436516
[TBL] [Abstract][Full Text] [Related]
14. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Gappa M; Steinkamp G; Tümmler B; von der Hardt H
Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA
J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602
[TBL] [Abstract][Full Text] [Related]
16. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
17. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
Regelmann WE; Elliott GR; Warwick WJ; Clawson CC
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):914-21. PubMed ID: 2109558
[TBL] [Abstract][Full Text] [Related]
18. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa infection: pathogenesis and therapy.
Pennington JE
Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
[No Abstract] [Full Text] [Related]
20. Progressive necrotizing external otitis: treatment with ticarcillin and tobramycin.
Horwitz MJ; Templeton TP
Laryngoscope; 1977 Nov; 87(11):1836-40. PubMed ID: 199816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
